Management tracks: Bailey leaving GSK; plus HHS drug pricing adviser to depart and more

Jack Bailey will step down as president of U.S. Pharmaceuticals at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) at year end. He will be replaced by Maya Martinez-Davis, who is

Read the full 277 word article

User Sign In